Nov 13, 2017 12:00 pm UTC| Business
CARMIEL, Israel, Nov. 13, 2017 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed...
Spero Therapeutics Announces Underwriters’ Option Exercise
Nov 13, 2017 12:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 13, 2017 -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug...
Nov 13, 2017 12:00 pm UTC| Business
NEW HAVEN, Conn., Nov. 13, 2017 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT) a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today that the...
Nov 13, 2017 12:00 pm UTC| Business
Denver, Colo., Nov. 13, 2017 -- The American Indian College Fund leads the nation in supporting development of culturally relevant early childhood education programs at tribal colleges and universities to secure the...
Nov 13, 2017 12:00 pm UTC| Business
THE COLONY, Texas, Nov. 13, 2017 -- Quest Resource Holding Corporation (NASDAQ:QRHC) ("Quest"), a leader in sustainability, recycling, and environmental services, announced today that its Chief Executive Officer, Ray...
Nov 13, 2017 12:00 pm UTC| Business
FORT LAUDERDALE, Fla., Nov. 13, 2017 -- SEACOR Holdings Inc. (NYSE:CKH) (“SEACOR” or the “Company”) announced today that it is notifying holders of its 2.50% Convertible Senior Notes due 2027 (CUSIP Number: 811904 AM3)...
Karyopharm Therapeutics to Present at the Jefferies 2017 London Healthcare Conference
Nov 13, 2017 12:00 pm UTC| Business
NEWTON, Mass., Nov. 13, 2017 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will present at the Jefferies...